Literature DB >> 19282194

Development of a new design (125)I-brachytherapy seed for its application in the treatment of eye and prostate cancer.

Sanjay Kumar Saxena1, S D Sharma, Ashutosh Dash, Meera Venkatesh.   

Abstract

Palladium coated silver beads of 0.5mm (slashed circle) were used to adsorb (125)I and encapsulated inside a titanium capsule by Nd:YAG laser, for use as a brachytherapy source. Experimental conditions were optimized for maximum adsorption of (125)I and uniformity of radioactivity was ascertained. Leachability of (125)I was found to be<0.01%. The dose rate constant of the new source was estimated to be 1.045cGyh(-1)U(-1). This newly developed source could be an alternative to other (125)I sources.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282194     DOI: 10.1016/j.apradiso.2009.02.040

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  1 in total

1.  Bioevaluation of (125) I Ocu-Prosta seeds for application in prostate cancer brachytherapy.

Authors:  Archana Mukherjee; Haladhar Dev Sarma; Sanjay Saxena; Yogendra Kumar; Pradip Chaudhari; Jayant Sastri Goda; Pranjal Adurkar; Ashutosh Dash; Grace Samuel
Journal:  Indian J Med Res       Date:  2014-04       Impact factor: 2.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.